|
|
||||||||
Original Research Communications |
1 From the Department of Food Science and Human Nutrition, Human Metabolic Unit, Center for Designing Foods to Improve Nutrition, the Department of Statistics, Iowa State University, Ames, and the Research and Development Laboratory, Fujicco Co, Ltd, Kobe Hyogo, Japan.
Background: No published studies have directly examined the effect of soy protein with isoflavones on bone or bone turnover in perimenopausal women.
Objective: Our objective was to determine the effects of 24 wk of consumption of soy protein isolate with isoflavones (80.4 mg/d) in attenuating bone loss during the menopausal transition.
Design: Perimenopausal subjects were randomly assigned, double blind, to treatment: isoflavone-rich soy (SPI+; n = 24), isoflavone-poor soy (SPI-; n = 24), or whey (control; n = 21) protein. At baseline and posttreatment, lumbar spine bone mineral density (BMD) and bone mineral content (BMC) were measured by using dual-energy X-ray absorptiometry. At baseline, midtreatment, and posttreatment, urinary N-telopeptides and serum bone-specific alkaline phosphatase (BAP) were measured.
Results: The percentage change in lumbar spine BMD and BMC, respectively, did not differ from zero in the SPI+ or SPI- groups, but loss occurred in the control group (-1.28%, P = 0.0041; -1.73%, P = 0.0037). By regression analysis, SPI+ treatment had a positive effect on change in BMD (5.6%; P = 0.023) and BMC (10.1%; P = 0.0032). Baseline BMD and BMC (P
0.0001) negatively affected the percentage change in their respective models; baseline body weight (P = 0.0036) and bone-free lean weight (P = 0.016) contributed positively to percentage change in BMD and BMC, respectively. Serum BAP posttreatment was negatively related to percentage change in BMD (P = 0.0016) and BMC (P = 0.019). Contrast coding using analyses of covariance with BMD or BMC as the outcome showed that isoflavones, not soy protein, exerted the effect.
Conclusion: Soy isoflavones attenuated bone loss from the lumbar spine in perimenopausal women.
Key Words: Soy isoflavones bone density lumbar vertebrae biochemical markers menopause bone mineral content perimenopausal women
This article has been cited by other articles:
![]() |
A. M Kenny, K. M Mangano, R. H Abourizk, R. S Bruno, D. E Anamani, A. Kleppinger, S. J Walsh, K. M Prestwood, and J. E Kerstetter Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial Am. J. Clinical Nutrition, July 1, 2009; 90(1): 234 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hooper, J.J. Ryder, M.S. Kurzer, J.W. Lampe, M.J. Messina, W.R. Phipps, and A. Cassidy Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis Hum. Reprod. Update, July 1, 2009; 15(4): 423 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Johnson, E. A. Lucas, S. Hooshmand, S. Campbell, M. P. Akhter, and B. H. Arjmandi Addition of Fructooligosaccharides and Dried Plum to Soy-based Diets Reverses Bone Loss in the Ovariectomized Rat Evid. Based Complement. Altern. Med., July 30, 2008; (2008) nen050v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M Ritland, D L. Alekel, O. A Matvienko, K. B Hanson, J. W Stewart, L. N Hanson, M. B Reddy, M. D Van Loan, and U. Genschel Centrally located body fat is related to appetitive hormones in healthy postmenopausal women. Eur. J. Endocrinol., June 1, 2008; 158(6): 889 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Poulsen, P. J. Moughan, and M. C. Kruger Docosahexaenoic Acid and 17{beta}-Estradiol Co-Treatment Is More Effective Than 17{beta}-Estradiol Alone in Maintaining Bone Post-Ovariectomy Experimental Biology and Medicine, May 1, 2008; 233(5): 592 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mardon, J. Mathey, S. Kati-Coulibaly, C. Puel, M.-J. Davicco, P. Lebecque, M.-N. Horcajada, and V. Coxam Influence of Lifelong Soy Isoflavones Consumption on Bone Mass in the Rat Experimental Biology and Medicine, February 1, 2008; 233(2): 229 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Farag, D. V. Huhman, R. A. Dixon, and L. W. Sumner Metabolomics Reveals Novel Pathways and Differential Mechanistic and Elicitor-Specific Responses in Phenylpropanoid and Isoflavonoid Biosynthesis in Medicago truncatula Cell Cultures Plant Physiology, February 1, 2008; 146(2): 387 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. K. Cheong, B. R. Martin, G. S. Jackson, D. Elmore, G. P. McCabe, J. R. Nolan, S. Barnes, M. Peacock, and C. M. Weaver Soy Isoflavones Do Not Affect Bone Resorption in Postmenopausal Women: A Dose-Response Study Using a Novel Approach with 41Ca J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 577 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N Hanson, H. M Engelman, D L. Alekel, K. L Schalinske, M. L Kohut, and M. B Reddy Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 774 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kerstetter, D. E. Wall, K. O. O'Brien, D. M. Caseria, and K. L. Insogna Meat and Soy Protein Affect Calcium Homeostasis in Healthy Women J. Nutr., July 1, 2006; 136(7): 1890 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bunout, G. Barrera, L. Leiva, V. Gattas, M. P. de la Maza, F. Haschke, P. Steenhout, P. Klassen, C. Hager, E. Offord, et al. Effect of a Nutritional Supplementation on Bone Health in Chilean Elderly Subjects with Femoral Osteoporosis J. Am. Coll. Nutr., June 1, 2006; 25(3): 170 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A Ryan-Borchers, J. S. Park, B. P Chew, M. K McGuire, L. R Fournier, and K. A Beerman Soy isoflavones modulate immune function in healthy postmenopausal women Am. J. Clinical Nutrition, May 1, 2006; 83(5): 1118 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Whelan, T. M Jurgens, and S. K Bowles Natural Health Products in the Prevention and Treatment of Osteoporosis: Systematic Review of Randomized Controlled Trials Ann. Pharmacother., May 1, 2006; 40(5): 836 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, M. Winston, and for the American Heart Association Nutrition Commi Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee Circulation, February 21, 2006; 113(7): 1034 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R Mundy Nutritional modulators of bone remodeling during aging Am. J. Clinical Nutrition, February 1, 2006; 83(2): 427S - 430S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reimann, J. Dierkes, A. Carlsohn, D. Talbot, M. Ferrari, J. Hallund, W. L. Hall, K. Vafeiadou, U. Huebner, F. Branca, et al. Consumption of Soy Isoflavones Does Not Affect Plasma Total Homocysteine or Asymmetric Dimethylarginine Concentrations in Healthy Postmenopausal Women J. Nutr., January 1, 2006; 136(1): 100 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, X.-O. Shu, H. Li, G. Yang, Q. Li, Y.-T. Gao, and W. Zheng Prospective Cohort Study of Soy Food Consumption and Risk of Bone Fracture Among Postmenopausal Women Arch Intern Med, September 12, 2005; 165(16): 1890 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Weaver and J. M. K. Cheong Soy Isoflavones and Bone Health: The Relationship Is Still Unclear J. Nutr., May 1, 2005; 135(5): 1243 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A Spence, E. R Lipscomb, J. Cadogan, B. Martin, M. E Wastney, M. Peacock, and C. M Weaver The effect of soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomized crossover study Am. J. Clinical Nutrition, April 1, 2005; 81(4): 916 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dodin, A. Lemay, H. Jacques, F. Legare, J.-C. Forest, and B. Masse The Effects of Flaxseed Dietary Supplement on Lipid Profile, Bone Mineral Density, and Symptoms in Menopausal Women: A Randomized, Double-Blind, Wheat Germ Placebo-Controlled Clinical Trial J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1390 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Williamson and C. Manach Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 243S - 255S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. K. Roughead, J. R. Hunt, L. K. Johnson, T. M. Badger, and G. I. Lykken Controlled Substitution of Soy Protein for Meat Protein: Effects on Calcium Retention, Bone, and Cardiovascular Health Indices in Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 181 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, S.-O. Lee, M. A. Verbruggen, P. A. Murphy, and S. Hendrich The Apparent Absorptions of Isoflavone Glucosides and Aglucons Are Similar in Women and Are Increased by Rapid Gut Transit Time and Low Fecal Isoflavone Degradation J. Nutr., October 1, 2004; 134(10): 2534 - 2539. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fujioka, M. Uehara, J. Wu, H. Adlercreutz, K. Suzuki, K. Kanazawa, K. Takeda, K. Yamada, and Y. Ishimi Equol, a Metabolite of Daidzein, Inhibits Bone Loss in Ovariectomized Mice J. Nutr., October 1, 2004; 134(10): 2623 - 2627. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nikander, M. Metsa-Heikkila, O. Ylikorkala, and A. Tiitinen Effects of Phytoestrogens on Bone Turnover in Postmenopausal Women with a History of Breast Cancer J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1207 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Brooks, W. E Ward, J. E Lewis, J. Hilditch, L. Nickell, E. Wong, and L. U Thompson Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy Am. J. Clinical Nutrition, February 1, 2004; 79(2): 318 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atkinson, J. E Compston, N. E Day, M. Dowsett, and S. A Bingham The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial Am. J. Clinical Nutrition, February 1, 2004; 79(2): 326 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Muhlbauer, A. Lozano, A. Reinli, and H. Wetli Various Selected Vegetables, Fruits, Mushrooms and Red Wine Residue Inhibit Bone Resorption in Rats J. Nutr., November 1, 2003; 133(11): 3592 - 3597. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Chen, S. C. Ho, S. S. H. Lam, S. S. S. Ho, and J. L. F. Woo Soy Isoflavones Have a Favorable Effect on Bone Loss in Chinese Postmenopausal Women with Lower Bone Mass: A Double-Blind, Randomized, Controlled Trial J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4740 - 4747. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, J. Hu, P. A. Murphy, D. L. Alekel, W. D. Franke, and S. Hendrich Rapid Gut Transit Time and Slow Fecal Isoflavone Disappearance Phenotype Are Associated with Greater Genistein Bioavailability in Women J. Nutr., October 1, 2003; 133(10): 3110 - 3116. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Setchell and E. Lydeking-Olsen Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies Am. J. Clinical Nutrition, September 1, 2003; 78(3): 593S - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Register, M. J. Jayo, and M. S. Anthony Soy Phytoestrogens Do Not Prevent Bone Loss in Postmenopausal Monkeys J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4362 - 4370. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Piersen Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138. [Abstract] [PDF] |
||||
![]() |
M. S. Kurzer Phytoestrogen Supplement Use by Women J. Nutr., June 1, 2003; 133(6): 1983S - 1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cabot Phytoestrogens J. Am. Acad. Ortho. Surg., May 1, 2003; 11(3): 153 - 156. [Full Text] [PDF] |
||||
![]() |
S. C. Blum, S. N. Heaton, B. M. Bowman, M. Hegsted, and S. C. Miller Dietary Soy Protein Maintains Some Indices of Bone Mineral Density and Bone Formation in Aged Ovariectomized Rats J. Nutr., May 1, 2003; 133(5): 1244 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Arjmandi, D. A. Khalil, B. J. Smith, E. A. Lucas, S. Juma, M. E. Payton, and R. A. Wild Soy Protein Has a Greater Effect on Bone in Postmenopausal Women Not on Hormone Replacement Therapy, as Evidenced by Reducing Bone Resorption and Urinary Calcium Excretion J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1048 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Dixon and L. W. Sumner Legume Natural Products: Understanding and Manipulating Complex Pathways for Human and Animal Health Plant Physiology, March 1, 2003; 131(3): 878 - 885. [Full Text] [PDF] |
||||
![]() |
Y. Yamori, E. H. Moriguchi, T. Teramoto, A. Miura, Y. Fukui, K.-i. Honda, M. Fukui, Y. Nara, K. Taira, and Y. Moriguchi Soybean Isoflavones Reduce Postmenopausal Bone Resorption in Female Japanese Immigrants in Brazil: A Ten-Week Study J. Am. Coll. Nutr., December 1, 2002; 21(6): 560 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones J. Nutr., December 1, 2002; 132(12): 3577 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-J. Liu, J. W. Blount, C. L. Steele, and R. A. Dixon Bottlenecks for metabolic engineering of isoflavone glycoconjugates in Arabidopsis PNAS, October 29, 2002; 99(22): 14578 - 14583. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. B. Anderson, X. Chen, A. Boass, M. Symons, M. Kohlmeier, J. B. Renner, and S. C. Garner Soy Isoflavones: No Effects on Bone Mineral Content and Bone Mineral Density in Healthy, Menstruating Young Adult Women after One Year J. Am. Coll. Nutr., October 1, 2002; 21(5): 388 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Khalil, E. A. Lucas, S. Juma, B. J. Smith, M. E. Payton, and B. H. Arjmandi Soy Protein Supplementation Increases Serum Insulin-Like Growth Factor-I in Young and Old Men but Does Not Affect Markers of Bone Metabolism J. Nutr., September 1, 2002; 132(9): 2605 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H Swain, D L. Alekel, S. B Dent, C. T Peterson, and M. B Reddy Iron indexes and total antioxidant status in response to soy protein intake in perimenopausal women Am. J. Clinical Nutrition, July 1, 2002; 76(1): 165 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ohta, M. Uehara, K. Sakai, M. Takasaki, H. Adlercreutz, T. Morohashi, and Y. Ishimi A Combination of Dietary Fructooligosaccharides and Isoflavone Conjugates Increases Femoral Bone Mineral Density and Equol Production in Ovariectomized Mice J. Nutr., July 1, 2002; 132(7): 2048 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Boker, Y. T. Van der Schouw, M. J. J. De Kleijn, P. F. Jacques, D. E. Grobbee, and P. H. M. Peeters Intake of Dietary Phytoestrogens by Dutch Women J. Nutr., June 1, 2002; 132(6): 1319 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Greendale, G. FitzGerald, M.-H. Huang, B. Sternfeld, E. Gold, T. Seeman, S. Sherman, and M. Sowers Dietary Soy Isoflavones and Bone Mineral Density: Results from the Study of Women's Health Across the Nation Am. J. Epidemiol., April 15, 2002; 155(8): 746 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Messina, C. Gardner, and S. Barnes Gaining Insight into the Health Effects of Soy but a Long Way Still to Go: Commentary on the Fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease J. Nutr., March 1, 2002; 132(3): 547S - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mei, S. S. C. Yeung, and A. W. C. Kung High Dietary Phytoestrogen Intake Is Associated with Higher Bone Mineral Density in Postmenopausal but Not Premenopausal Women J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5217 - 5221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Atkinson and W. E. Ward Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis Can. Med. Assoc. J., November 1, 2001; 165(11): 1511 - 1514. [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell Soy Isoflavones--Benefits and Risks from Nature's Selective Estrogen Receptor Modulators (SERMs) J. Am. Coll. Nutr., October 1, 2001; 20(90005): 354S - 362. [Abstract] [Full Text] |
||||
![]() |
B. H. Arjmandi The Role of Phytoestrogens in the Prevention and Treatment of Osteoporosis in Ovarian Hormone Deficiency J. Am. Coll. Nutr., October 1, 2001; 20(90005): 398S - 402. [Abstract] [Full Text] |
||||
![]() |
S. B. Dent, C. T. Peterson, L. D. Brace, J. H. Swain, M. B. Reddy, K. B. Hanson, J. G. Robinson, and D. L. Alekel Soy Protein Intake by Perimenopausal Women Does Not Affect Circulating Lipids and Lipoproteins or Coagulation and Fibrinolytic Factors J. Nutr., September 1, 2001; 131(9): 2280 - 2287. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Anderson; Soy Phytoestrogens, Lipid Reductions, and Atherosclerosis Delay in Ovariectomized Primates J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 39 - 40. [Full Text] |
||||
![]() |
J. W Erdman Jr, R. J Stillman, and R. A Boileau Provocative relation between soy and bone maintenance Am. J. Clinical Nutrition, September 1, 2000; 72(3): 679 - 680. [Full Text] [PDF] |
||||
![]() |
J. An, C. Tzagarakis-Foster, T. C. Scharschmidt, N. Lomri, and D. C. Leitman Estrogen Receptor beta -Selective Transcriptional Activity and Recruitment of Coregulators by Phytoestrogens J. Biol. Chem., May 18, 2001; 276(21): 17808 - 17814. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |